|
1
|
Taniguchi T, Ogasawara K, Takaoka A and
Tanaka N: IRF family of transcription factors as regulators of host
defense. Annu Rev Immunol. 19:623–655. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Paun A and Pitha PM: The IRF family,
revisited. Biochimie. 89:744–753. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mamane Y, Heylbroeck C, Genin P, et al:
Interferon regulatory factors: the next generation. Gene. 237:1–14.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Takaoka A, Tamura T and Taniguchi T:
Interferon regulatory factor family of transcription factors and
regulation of oncogenesis. Cancer Sci. 99:467–478. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Evsyukova I, Somarelli JA, Gregory SG and
Garcia-Blanco MA: Alternative splicing in multiple sclerosis and
other autoimmune diseases. RNA Biol. 7:462–473. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Onouchi Y, Gunji T, Burns JC, et al: ITPKC
functional polymorphism associated with Kawasaki disease
susceptibility and formation of coronary artery aneurysms. Nat
Genet. 40:35–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kozyrev SV, Abelson AK, Wojcik J, et al:
Functional variants in the B-cell gene BANK1 are associated with
systemic lupus erythematosus. Nat Genet. 40:211–216. 2008.
View Article : Google Scholar
|
|
8
|
Brenner T, Hamra-Amitay J, Evron T, Boneva
N, Seidman S and Soreq H: The role of readthrough
acetylcholinesterase in the pathophysiology of myasthenia gravis.
FASEB J. 17:214–222. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Karpova AY, Ronco LV and Howley PM:
Functional characterization of interferon regulatory factor 3a
(IRF-3a), an alternative splice isoform of IRF-3. Mol Cell Biol.
21:4169–4176. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Y, Hu X, Song Y, Lu Z, Ning T, Cai H
and Ke Y: Identification of novel alternative splicing variants of
interferon regulatory factor 3. Biochim Biophys Acta. 1809:166–175.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ren W, Xu HG, Lu C, Jin R, Zou L, Wang Y
and Zhou GP: The characterization of two novel IRF-3 transcripts
starting from intron 2 of the wild type of IRF-3. Mol Biol Rep.
38:4415–4421. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ren W, Zhu LH, Xu HG, Jin R and Zhou GP:
Characterization of a spliced variant of human IRF-3 promoter and
its regulation by the transcription factor Sp1. Mol Biol Rep.
39:6987–6993. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Krüger I, Vollmer M, Simmons DG, Elsässer
HP, Philipsen S and Suske G: Sp1/Sp3 compound heterozygous mice are
not viable: impaired erythropoiesis and severe placental defects.
Dev Dyn. 236:2235–2244. 2007.PubMed/NCBI
|
|
14
|
Bourdon JC, Fernandes K, Murray-Zmijewski
F, et al: p53 isoforms can regulate p53 transcriptional activity.
Genes Dev. 19:2122–2137. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu HG, Ren W, Lu C and Zhou GP:
Characterization of the human IRF-3 promoter and its regulation by
the transcription factor E2F1. Mol Biol Rep. 37:3073–3080. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu HG, Ren W, Zou L, Wang Y, Jin R and
Zhou GP: Direct repression of the human IRF-3 promoter by E2F1.
Immunogenetics. 63:189–196. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Noda C, Murata T, Kanda T, et al:
Identification and characterization of CCAAT enhancer-binding
protein (C/EBP) as a transcriptional activator for Epstein-Barr
virus oncogene latent membrane protein 1. J Biol Chem.
286:42524–42533. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chang LK, Chung JY, Hong YR, Ichimura T,
Nakao M and Liu ST: Activation of Sp1-mediated transcription by Rta
of Epstein-Barr virus via an interaction with MCAF1. Nucleic Acids
Res. 33:6528–6539. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sankpal UT, Goodison S, Abdelrahim M and
Basha R: Targeting Sp1 transcription factors in prostate cancer
therapy. Med Chem. 7:518–525. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Suzuki T, Kimura A, Nagai R and Horikoshi
M: Regulation of interaction of the acetyltransferase region of
p300 and the DNA-binding domain of Sp1 on and through DNA binding.
Genes Cells. 5:29–41. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao S, Venkatasubbarao K, Li S and
Freeman JW: Requirement of a specific Sp1 site for histone
deacetylase-mediated repression of transforming growth factor beta
type II receptor expression in human pancreatic cancer cells.
Cancer Res. 63:2624–2630. 2003.
|
|
22
|
Xu HG, Ren W, Zou L, Wang Y, Jin R and
Zhou GP: Transcriptional control of human CD2AP expression: the
role of Sp1 and Sp3. Mol Biol Rep. 39:1479–1486. 2012. View Article : Google Scholar : PubMed/NCBI
|
